2.25

2.25 (-1.74%)

As of Jun 14, 2022

Indaptus Therapeutics, Inc. [INDP]

Source: 

Company Overview

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy.We have evolved from more than a century of immunotherapy advances.

CountryUS
Headquartersnew yorknew york
Phone Number(646) 427-2727
Industry
CEOJeffrey A. Meckler
Websitehttp://www.indaptusrx.com

Recent Stories